Validation of the Behçet’s syndrome Overall Damage Index in patients with Behçet’s disease in the Behçet’s clinic of Tabriz Imam-Reza Hospital
Abstract
In the present study, we aimed to validate the Behçet's syndrome Overall Damage Index (BODI) and compare its performance with that of Vasculitis Damage Index (VDI) in Iranian patients with BD.
Materials and Methods: This study included 274 patients with a diagnosis of BD and median follow up of 40 months. The medical records of the patients were reviewed and the demographic characteristics, disease activity status, clinical manifestations, and data on organs damage were collected from all patients.
Results: To evaluate the construct/convergent validity, BODI and VDI were applied to all participants. We found a good correlation between BODI score and VDI score. There was a significant and strong correlation between physician global assessment with BODI (r=0.869, P= 0.001) and VDI (r=0.817, P= 0.001). The ability of BODI to determine the accumulation of damage over time was assessed by analyzing the changes in BODI score over time. The increase in BODI score was occurred in 53 (19.3%) patients. In comparison, the increase in VDI score occurred in 36 (13.1%) patients. The increase in median BODI was significantly more than median VDI (P < 0.001). Multiple linear regression analysis showed that age at disease onset, disease duration, and disease severity were independent predictors of BODI scores. Reliability of BODI was examined by comparing the BODI scores as determined by two independent assessors in 100 patients. Cronbach’s α was 0.942.
Collections
Related items
Showing items related by title, author, creator and subject.
-
Methylation Status of Interleukin-6 Gene Promoter in Patients with Behçet's Disease [Estatus de la metilaci?n del promotor del gen interleucina-6 en pacientes con s?ndrome de Behçet]
Alipour, S; Sakhinia, E; Khabbazi, A; Samadi, N; Babaloo, Z; Azad, M; Abolhasani, S; Farhadi, J; Jadideslam, G; Roshanravan, N; Nouri, M (2018)Background: IL-6 mRNA expression is significantly high in many autoimmune diseases such as Behçet's disease; this is often related with more aggressive phenotypes. Nevertheless, the essential molecular process for its high ... -
Comparison of smoking status between Behçet patients and healthy subjects and its relationship with clinical manifestations, disease activity and quality of life in patients with Behçet’s disease
Aghamohammadi, Ramin (Tabriz University of Medical Sciences, Faculty of Medicine, 2019)This case-control study was conducted to investigate the association between smoking and the risk of BD. Methods: We included 192 patients with BD and 822 healthy siblings of patient with BD and 373 healthy unrelated ... -
Adherence to treatment in patients with Behcet's disease
Khabbazi, A; Karkon Shayan, F; Ghojazadeh, M; Kavandi, H; Hajialiloo, M; Esalat Manesh, K; Kolahi, S (2017)Aim: Behcet's disease (BD) is a chronic, inflammatory disease with multisystem involvement. Adherence to treatment is low in chronic diseases as well as inflammatory and autoimmune diseases. This study assessed factors ...